Drug Information

Drug General Information
Drug ID
D0D4CY
Former ID
DAP001200
Drug Name
Sulfapyridine
Synonyms
Adiplon; Coccoclase; Dagenan; Eubasin; Eubasinum; Haptocil; Piridazol; Plurazol; Pyriamid; Pyridazol; Relbapiridina; Ronin;Septipulmon; Solfapiridina; Streptosilpyridine; Sulfapiridina; Sulfapyridinum; Sulfidin; Sulfidine; Sulphapyridin; Sulphapyridine; Thioseptal; Trianon; Solfapiridina [DCIT]; M and B 693; A-499; ALBB-006215; M + B 693; M&B 693; M+B 693; Sulfapiridina [INN-Spanish]; Sulfapyridine (TN); Sulfapyridinum [INN-Latin]; AO-801/41077453; N(1)-Pyridylsulfanilamide; N(sup1)-Pyridylsulfanilamide; N-2-Pyridylsulfanilamide; N1-2-Pyridylsulfanilamide; Sulfapyridine (USP/INN); Sulfapyridine [USAN:INN:BAN]; N'-2-Pyridylsulfanilide; N(1)-2-Pyridylsulfanilamide; N(sup 1)-2-Pyridylsulfanilamide; N1-(Pyridin-2-yl)sulfanilamide; Sulfanilamide, N1-2-pyridyl-(8CI); 2-(4-Aminobenzenesulfonamido)pyridine; 2-(p-Aminobenzenesulphonamido)pyridine; 2-Sulfanilamidopyridin; 2-Sulfanilamidopyridin [German]; 2-Sulfanilamidopyridine; 2-Sulfanilyl aminopyridine; 2-Sulfanilylaminopyridine; 2-Sulfapyridine; 4-(2-Pyridinylsulfonyl)aniline; 4-AMINO-N-2-PYRIDINYLBENZENESULFONAMIDE; 4-Amino-N,2-pyridinylbenzenesulfonamide; 4-Amino-N-2-pyridinyl-benzenesulfonamide; 4-Amino-N-[2-pyridyl]benzene sulfonamide; 4-[(2-Pyridylamino)sulfonyl]aniline; 4-amino-N-(pyridin-2-yl)benzenesulfonamide; 4-amino-N-pyridin-2-yl-benzenesulfonamide; 4-amino-N-pyridin-2-ylbenzenesulfonamide
Drug Type
Small molecular drug
Indication Dermatitis herpetiformis [ICD9: 694; ICD10:L12.2, L13] Approved [538383], [551871]
Therapeutic Class
Dermatologic Agents
Structure
Download
2D MOL

3D MOL
Formula
C11H11N3O2S
Canonical SMILES
C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N
InChI
1S/C11H11N3O2S/c12-9-4-6-10(7-5-9)17(15,16)14-11-3-1-2-8-13-11/h1-8H,12H2,(H,13,14)
InChIKey
GECHUMIMRBOMGK-UHFFFAOYSA-N
CAS Number
CAS 144-83-2
PubChem Compound ID
5336
PubChem Substance ID
70988, 96525, 603199, 855656, 866442, 5631195, 7820105, 7849492, 7980704, 8149538, 8153278, 10321924, 10508192, 11112302, 11335391, 11360630, 11363890, 11366452, 11369014, 11372864, 11373890, 11377176, 11461602, 11466790, 11467910, 11485181, 11486479, 11489139, 11491588, 11492161, 11494810, 15221159, 17140599, 24899692, 26611930, 26679786, 26746948, 29224390, 46506991, 47291019, 47365061, 47365062, 47515199, 47662144, 47736350, 48110333, 48110334, 48424128, 49698734, 49855022
SuperDrug ATC ID
J01EB04
SuperDrug CAS ID
cas=000144832
Target and Pathway
Target(s) Dihydropteroate synthetase Target Info Inhibitor [537591]
References
Ref 538383FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 000159.
Ref 551871Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
Ref 537591A confirmatory method for the simultaneous extraction, separation, identification and quantification of Tetracycline, Sulphonamide, Trimethoprim and Dapsone residues in muscle by ultra-high-performance liquid chromatography-tandem mass spectrometry according to Commission Decision 2002/657/EC. J Chromatogr A. 2009 Jun 9.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.